1. Department of Genetics, Federal University of Pernambuco, Recife, Brazil;
2. Department of Internal Medicine, Medical School of Ribeirao Preto, and
3. Center for Cell Based Therapy, University of Sao Paulo, Ribeirao Preto, Brazil;
4. Hematology Division, Faculdade de Medicina, University of Sao Paulo, Sao Paulo, Brazil;
5. Department of Internal Medicine, University of Pernambuco, Recife, Brazil;
6. Hematology Division, Federal University of Rio Grande do Sul, Porto Alegre, Brazil;
7. Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil;
8. Hematology Division, Federal University of Parana, Curitiba, Brazil;
9. Hematology Division, Federal University of Minas Gerais, Belo Horizonte, Brazil;
10. Department of Hematology, Federal University of Sao Paulo, Sao Paulo, Brazil;
11. Department of Haematology, Churchill Hospital, Oxford University, Oxford, United Kingdom;
12. Princess Margaret Cancer Centre, Toronto, ON, Canada;
13. Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY;
14. Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN;
15. Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom;
16. Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany;
17. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands;
18. Department of Biopathology, University Tor Vergata, Rome, Italy;
19. Unit of Neuro-oncohematology, Santa Lucia Foundation, Rome, Italy;
20. Department of Hematology, Valencia University Medical School, Valencia, Spain;
21. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain; and
22. Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA